Operations Resuming Following Severe Weather

Gene ResultsPayment Portal
Login

Product Updates

Test Launch // Whole Genome Sequencing Reanalysis
Test Launch // Whole Genome Sequencing Reanalysis
Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine our test menu and services, we want you to be the first to know about changes that may affect ...
Read More
Test Launch // Whole Exome Sequencing & Whole Genome Sequencing (Rapid, Proband, & Duo)
Test Launch // Whole Exome Sequencing & Whole Genome Sequencing (Rapid, Proband, & Duo)
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine our test menu and services, we want you to be the first to know about changes ...
Read More
Test Launch // Rapid Whole Genome Sequencing
Test Launch // Rapid Whole Genome Sequencing
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner, as we continually upgrade and refine our test menu and services, we want you to be the first to know about the changes ...
Read More
Test Update // Whole Genome Sequencing
Test Update // Whole Genome Sequencing
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continually upgrade and refine our test menu and services, we want you to be the first to know about the changes ...
Read More
Test Update // Whole Exome Sequencing
Test Update // Whole Exome Sequencing
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine our test menu and services, we want you to be the first to know about changes ...
Read More
Test Discontinuation // Pyrosequencing
Test Discontinuation // Pyrosequencing
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continually upgrade and refine our test menu and services, we want you to be the first to know about the changes ...
Read More
Test Update // Report Improvements: Whole Genome & Exome Sequencing
Test Update // Report Improvements: Whole Genome & Exome Sequencing
Dear Valued Clients,  Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine our test menu and services, we want you to be the first to know about changes ...
Read More
Test Update // Chromosomal Microarray Analysis
Test Update // Chromosomal Microarray Analysis
Dear Valued Clients,  Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine our test menu and services, we want you to be the first to know about changes ...
Read More
Screen Shot 2022-04-05 at 4.11.52 PM
Test Update // Relaunch of BluePrint Panel
Dear Valued Clients,  Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continually upgrade and refine our test menu and services, we want you to be the first to know about the changes ...
Read More
Test Update // Pausing COVID-19 Testing Services
Test Update // Pausing COVID-19 Testing Services
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine our test menu and services, we want you to be the first to know about changes ...
Read More
Test Update // Whole Exome Sequencing
Test Update // Whole Exome Sequencing
Dear Valued Clients,  Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine our test menu and services, we want you to be the first to know about changes ...
Read More
Test Update // PreSeek<sup><small>TM</small></sup>
Test Update // PreSeekTM
Dear Valued Clients,  Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine our test menu and services, we want you to be the first to know about changes ...
Read More
Test Update // GeneAware
Test Update // GeneAware
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine our test menu and services, we want you to be the first to know about changes ...
Read More
Test Update // Whole Exome Sequencing Reanalysis
Test Update // Whole Exome Sequencing Reanalysis
Effective December 30, 2022, Baylor Genetics updated our policy for Whole Exome Sequencing (WES) Reanalysis, test code 1900. The update includes the first reanalysis to be performed at no charge with a turnaround time of 2-3 weeks. The specific requisition to order reanalysis is ...
Read More
Test Updates // Oncology // FISH Panel Probes (Dec 2019)
Test Updates // Oncology // FISH Panel Probes (Dec 2019)
Dear Valued Clients, Effective December 16, 2019, in a continuing effort to optimize our offerings, Baylor Genetics has updated four FISH panels and will begin offering three new FISH panels. The changes to the probes used in each FISH panel ...
Read More
Test Updates // Oncology // FISH Panel Probes (October 2019)
Test Updates // Oncology // FISH Panel Probes (October 2019)
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continually upgrade and refine our test menu and services, we want you to be the first to know of changes that ...
Read More
Test Updates // Oncology // FISH Panel Probes
Test Updates // Oncology // FISH Panel Probes
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continually upgrade and refine our test menu and services, we want you to be the first to know of changes that ...
Read More
Test Updates Memorandum - Oncology
Test Updates Memorandum – Oncology
EFFECTIVE APRIL 16, 2018 THE FOLLOWING TEST UPDATE(S) WILL OCCUR: • Due to the limited clinical utility of assessing the SBDS gene for hereditary leukemia and lymphoma, the Hereditary Leukemia/Lymphoma Panel (test code 22704) will no longer include this gene ...
Read More
Test Updates Memorandum - Biochemical
Test Updates Memorandum – Biochemical
EFFECTIVE IMMEDIATELY, THE FOLLOWING TEST UPDATE(S) WILL OCCUR: Orotic Acid/Orotidine Determination - Urine (Test code 4210) Due to the unavailability of a key reagent, Baylor Genetics will officially discontinue orotidine determination as part of test code 4210. Test code 4210 ...
Read More
Test Updates Memorandum - Tumor Analysis
Test Updates Memorandum – Tumor Analysis
Effective immediately, the following test update(s) will occur: NPM1 Mutation by PCR and Fragment Analysis (test code 9005) has been updated by ARUP to include the following: Test name: NPM1 Mutation Detection by RT-PCR, Quantitative Methodology: Quantitative Reverse-Transcription Polymerase Chain ...
Read More
Test Updates Memorandum
Test Updates Memorandum
Effective January 9th, 2018, the following test updates will occur: Test Updates Our current SMN1 deletion analysis (test code 6059) will now include the analysis of copy number changes for both SMN1 and SMN2 genes. Transition period If you are ...
Read More
Test Updates Memorandum - Biochemical
Test Updates Memorandum – Biochemical
Effective August 31, 2017, in a continuing effort to optimize our offerings, these changes will be made. The turnaround time (TAT) for the following test codes will be updated to 16 days. Sulfocysteine Determination - Urine (TC 4225) Pyridoxine-Dependent Seizures ...
Read More
Test Reporting Updates Memorandum - Prenatal Chromosomal Microarray Analysis
Test Reporting Updates Memorandum – Prenatal Chromosomal Microarray Analysis
Effective July 5, 2017, in a continuing effort to optimize our offerings, the following changes will be made to the prenatal Chromosomal Microarray Analysis (CMA) tests. Our reporting policy for prenatal CMA has been updated, as shown in the detailed ...
Read More
Test Reporting Updates Memorandum - Exome
Test Reporting Updates Memorandum – Exome
In a continuing effort to optimize our offerings, the below detailed changes will be made to our exome platform offerings effective July 3, 2017. In summary these changes will include: For all exome tests offered by Baylor Genetics, the medically ...
Read More
Test Updates Memorandum - Single Gene Cancer Tests
Test Updates Memorandum – Single Gene Cancer Tests
Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continually upgrade and refine our test menu and services, we want you to be the first to know of changes that may affect your ...
Read More
Test Updates Memorandum - Biochemical
Test Updates Memorandum – Biochemical
In a continuing effort to optimize our offerings, the following changes will be made. Effective immediately The CPT codes and insurance prices for the following test codes have been updated. Global Metabolomic Assisted Pathway Screen - Plasma (Global MAPS)® (TC ...
Read More
Test Updates Memorandum - Test Code 4210
Test Updates Memorandum – Test Code 4210
Due to a widespread commercial shortage of a key reagent, we are unable to provide testing of orotidine in the following test: Orotic Acid/Orotidine Determination (TC 4210) Therefore, effective December 13, this test will include quantitative analysis of orotic acid ...
Read More
Test Updates Memorandum
Test Updates Memorandum
Effective December 12, 2016, in a continuing effort to optimize our offerings, these changes will be made. The TAT for the following test code will be updated to 21 days: Chromosomal Microarray Analysis - Tissue – Products of Conception (TC ...
Read More
Test Updates Memorandum - Mitochondrial
Test Updates Memorandum – Mitochondrial
Effective August 16, 2016, in a continuing effort to optimize our offerings, these changes will be made. The following panels will be updated by removing these genes: ACACA, ACACB, ACADL, ATP5O, COX4I1, COX7A1, CPT1B, MRPL40, MRPS18A, MRPS2, MRPS22, MRRF, MTHFD1L, ...
Read More
Test Updates Memorandum
Test Updates Memorandum
Effective December 9, 2015, Baylor Miraca Genetics Laboratories (BMGL) will rename the following tests: The Cancer Gene Mutation Panel Version 2 (test code 9705) will be the Solid Tumor Mutation Panel. The Leukemia Mutation Panel (test code 9715) will be ...
Read More
Test Update Memorandum
Test Update Memorandum
Baylor Miraca Genetics Laboratories (BMGL) is pleased to announce the GeneAware version 2 (v2) Ashkenazi Jewish panels, which now include over 35 genes analyzed by full gene sequencing with copy number analysis on selected genes. Effective August 10, 2015, the ...
Read More
Test Update Memorandum
Test Update Memorandum
The Baylor Miraca Genetics Laboratories (BMGL) is pleased to announce that effective May 26, 2015, the GeneAware carrier screen will now include over 150 genes analyzed by full gene sequencing with copy number analysis on selected genes. As of May ...
Read More
Test Updates Memorandum
Test Updates Memorandum
Effective December 20, 2014, the whole exome sequencing tests offered in our laboratory (test codes listed below) will no longer report variants in the mitochondrial genome (mtDNA). This decision was made due to the low positive mtDNA diagnostic rate in ...
Read More
Test Update Memorandum - FMR1 - Related Disorders Repeat Expansion Analysis
Test Update Memorandum – FMR1 – Related Disorders Repeat Expansion Analysis
Effective 5/17/2013, the Medical Genetics Laboratories at Baylor College of Medicine will change the methodology for FMR1 - Related Disorders Repeat Expansion Analysis. The following test codes will change: Test code 6032 (Repeat Expansion Analysis) will be replaced by test ...
Read More
Test Update Memorandum - White Blood Cell Cystine
Test Update Memorandum – White Blood Cell Cystine
The Baylor Medical Genetics Laboratories are constantly striving to improve our services to the clinical community. On March 12, 2013, our biochemical laboratory started to use an optimized protocol for cystine determination in white blood cells for test code 4627 ...
Read More
Test Consolidation Memorandum
Test Consolidation Memorandum
In a continuing effort to provide you with the most straightforward and efficient test ordering process, we are consolidating many of our test codes for cancer genetic testing. Effective November 20, 2014, one test code will encompass all appropriate specimen ...
Read More
Test Change Memorandum
Test Change Memorandum
Effective March 10, 2014, the Medical Genetics Laboratories at Baylor College of Medicine will supplant Test Code 3300 - Autosomal Dominant Progressive External Ophthalmoplegia (ad-PEO) Panel with Test Code 2140 - PEO Panel by Massively Parallel Sequencing (BCM-MitomeNGSSM). Test Code ...
Read More
Test Change Memorandum
Test Change Memorandum
Effective January 3, 2014, the Medical Genetics Laboratories at Baylor College of Medicine will supplant Test Code 3500 - Mitochondrial/Metabolic (MitoMet®) Microarray Analysis with Test Code 2000 - Mitochondrial/Metabolic (MitoMet®Plus) Microarray Analysis, which offers more extensive coverage. Most nuclear genes ...
Read More
Test Change Memorandum
Test Change Memorandum
Effective January 3, 2014, the Medical Genetics Laboratories at Baylor College of Medicine will supplant test codes 3000, 3005, and 3006 with test code 2010. The discontinued test codes are: Test Code 3000 - Mitochondrial DNA Common Mutations and Deletions ...
Read More
Test Change Memorandum - Chromosomal Microarray-SNP
Test Change Memorandum – Chromosomal Microarray-SNP
What has changed Effective December 1, 2012, the Medical Genetics Laboratories at Baylor College of Medicine will change the array platform for test code 7772 (Chromosomal Microarray Analysis - SNP). This array will change to a CytoScan HD platform and ...
Read More
Test Change Memorandum - Cystic Fibrosis
Test Change Memorandum – Cystic Fibrosis
What has changed Effective May 1st, 2012, the CFTR-Related Disorders Mutation Panel (Test Code 6014) will be replaced by a new panel with an increased amount of mutations detected. The new mutation panel (Test code 7600) will test for the ...
Read More
Test Discontinuation // Pyrosequencing
Test Discontinuation // Pyrosequencing
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continually upgrade and refine our test menu and services, we want you to be the first to know about the changes ...
Read More
Test Update // Pausing COVID-19 Testing Services
Test Update // Pausing COVID-19 Testing Services
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine our test menu and services, we want you to be the first to know about changes ...
Read More
Test Update // Cytogenetics Test Discontinuation
Test Update // Cytogenetics Test Discontinuation
Dear Valued Clients,  Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continually upgrade and refine our test menu and services, we want you to be the first to know about the changes ...
Read More
TEST UPDATE // SINGLE-GENE TEST DISCONTINUATIONS
TEST UPDATE // SINGLE-GENE TEST DISCONTINUATIONS
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continually upgrade and refine our test menu and services, we want you to be the first to know about the changes ...
Read More
Test Update // Global MAPS<sup><small>®</small></sup> (CSF)
Test Update // Global MAPS® (CSF)
Dear Valued Clients,  Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine our test menu and services, we want you to be the first to know about changes ...
Read More
Test Discontinuation // Cytogenetics
Test Discontinuation // Cytogenetics
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine our test menu and services, we want you to be the first to know about changes ...
Read More
Test Discontinuation // Biochemical
Test Discontinuation // Biochemical
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner.  As we continually upgrade and refine our test menu and services, we want you to be the first to know about the changes that may affect your testing with us.  September 26, 2020 will be the last day we offer the following biochemical tests. Any samples received on, or prior to this date will be processed and reported. Test Code  Test Description  4001  SCID Newborn Screening Follow-up Panel  4110  Phenylalanine Determination - ...
Read More
Temporary Test Discontinuation // CMA
Temporary Test Discontinuation // CMA
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine our test menu and services, we want you to be the first to know about changes ...
Read More
Test Discontinuation // Overgrowth Panel
Test Discontinuation // Overgrowth Panel
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continually upgrade and refine our test menu and services, we want you to be the first to know about the changes ...
Read More
Test Discontinuations // Hereditary Cancer Single Gene Panels
Test Discontinuations // Hereditary Cancer Single Gene Panels
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continually upgrade and refine our test menu and services, we want you to be the first to know about the changes ...
Read More
Test Discontinuation // ClariFind
Test Discontinuation // ClariFind
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continually upgrade and refine our test menu and services, we want you to be the first to know of changes that ...
Read More
Test Discontinuations // Molecular
Test Discontinuations // Molecular
Dear Valued Clients, Effective November 1, 2019 in a continuing effort to optimize our offerings, these changes will be made. The following test codes will be discontinued: Test Code Test Description 6098 HNPCC MSI and IHC SCREENING 9032 EGFR – ...
Read More
Test Discontinuations // Cyto-Biochemical
Test Discontinuations // Cyto-Biochemical
Dear Valued Clients, Effective January 29, 2020 in a continuing effort to optimize our offerings, these changes will be made. The following test codes will be discontinued: CYTOGENETICS Test Code Test Description 8060 FISH ANALYSIS - 1P/19Q CO-DELETION BY FISH ...
Read More
Test Discontinuations // Biochemical
Test Discontinuations // Biochemical
Dear Valued Clients, Effective May 8, 2019, in a continuing effort to optimize our offerings, these changes will be made. The following test codes will be discontinued: Test Code Test Description 4500 Lysosomal Acid Lipase Enzyme Analysis (Prenatal Diagnosis) 4502 Lysosomal ...
Read More
Test Discontinuation Memorandum - Tumor Analysis
Test Discontinuation Memorandum – Tumor Analysis
Effective immediately, the following test code(s) will be discontinued: PIK3CA Mutation Detection (Test code 9035) An alternative testing option offered by Baylor Genetics is the Solid Tumor Mutation Panel (Test code 9705), which includes PIK3CA. You may also refer to ...
Read More
Test Discontinuations Memorandum - Cancer
Test Discontinuations Memorandum – Cancer
Effective November 29, 2017 in a continuing effort to optimize our offerings, these changes will be made. The following test code(s) will be discontinued: Cancer Chromosomal Microarray Analysis - 400K CGH/SNP Array Test code (TC 9510) Alternative test(s): CytoScan HD ...
Read More
Test Discontinuations Memorandum - Cancer
Test Discontinuations Memorandum – Cancer
Effective November 29, 2017, in a continuing effort to optimize our offerings, these changes will be made. Test updates Cancer Chromosomal Microarray Analysis - 400K CGH/SNP Array Test code (TC) 9510 The test will be discontinued on November 29, 2017 ...
Read More
Test Discontinuations Memorandum - Biochemical
Test Discontinuations Memorandum – Biochemical
Effective August 31, 2017, in a continuing effort to optimize our offerings, these changes will be made. The following test code(s) will be discontinued: Vitamin D (25-hydroxyvitamin D2 and D3) (TC 4360) ...
Read More
Test Discontinuations Memorandum - Biochemical
Test Discontinuations Memorandum – Biochemical
In a continuing effort to optimize our offerings, the following changes will be made. Effective May 29, 2017 The following test codes will be discontinued: Aspartylglucosaminidase Enzyme Analysis (TC 4514) Beta-Galactosidase Enzyme Analysis - Skin Fibroblast (TC 4548) Beta-Galactosidase Enzyme ...
Read More
Test Discontinuations Memorandum - Single Gene Cancer Tests
Test Discontinuations Memorandum – Single Gene Cancer Tests
Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continually upgrade and refine our test menu and services, we want you to be the first to know of changes that may affect your ...
Read More
Test Discontinuation Memorandum
Test Discontinuation Memorandum
Effective February 27, 2017, in a continuing effort to optimize our offerings, these changes will be made. The following test code will be discontinued: CFTR-Related Disorders Mutation Panel - Prenatal Diagnosis (TC 7601) ...
Read More
Test Discontinuation Memorandum
Test Discontinuation Memorandum
Effective December 12, 2016, in a continuing effort to optimize our offerings, these changes will be made. The following test codes will be discontinued: GJB6 Gene Sequencing by Massively Parallel Sequencing (TC 29360) GJB6 Sequence Analysis – Known Familial Mutation ...
Read More
Test Discontinuation Memorandum
Test Discontinuation Memorandum
Effective August 31, 2016, in a continuing effort to optimize our offerings, these changes will be made. The following will be discontinued: Counsyl Universal Carrier Panel (TC 1200) Counsyl Prenatal Panel (TC 1201) Counsyl Fundamental Panel (TC 1202) Counsyl Fundamental ...
Read More
Test Discontinuation Memorandum
Test Discontinuation Memorandum
Effective August 31 2016, in a continuing effort to optimize our offerings, these changes will be made. The following will be discontinued: Alpha-Galactosidase A Enzyme Analysis on skin fibroblasts (TC 4516) Alpha-Galactosidase A Enzyme Analysis on WBC (TC 4517) Arylsulfatase ...
Read More
Test Discontinuations Memorandum - Mitochondrial
Test Discontinuations Memorandum – Mitochondrial
Effective August 16, 2016, in a continuing effort to optimize our offerings, these changes will be made. The following will be discontinued. Single gene components of each panel may also be affected. Tier 1 Severe Combined Immunodeficiency (SCID) Panel (TC ...
Read More
Test Discontinuation Memorandum
Test Discontinuation Memorandum
Effective May 9, 2016, Baylor Miraca Genetics Laboratories (BMGL) will discontinue the following tests: Test code 6055 – Spinocerebellar Ataxia Type 10 Repeat Expansion Analysis Test code 6054 – Spinocerebellar Ataxia Type 1 Repeat Expansion Analysis Test code 6027 – ...
Read More
Test Discontinuation Memorandum
Test Discontinuation Memorandum
Effective December 21, 2015, Baylor Miraca Genetics Laboratories (BMGL) will discontinue the following tests: Test code 6001 – Ashkenazic Genetic Disease Panel Test code 6030 - Familial Dysautonomia Ashkenazic Mutation Panel Test code 6033 – Gaucher Disease Ashkenazic Mutation Panel ...
Read More
Test Discontinuation Memorandum
Test Discontinuation Memorandum
Effective December 17, 2015, Baylor Miraca Genetics Laboratories (BMGL) will make the following modifications to its test menu: Test code 9506 (Chromosomal Microarray Analysis - 180K CGH/SNP Array for POC) will be replaced by test code 8639 (Chromosomal Microarray Analysis ...
Read More
Test Discontinuation Memorandum
Test Discontinuation Memorandum
Effective December 17, 2015, Baylor Miraca Genetics Laboratories (BMGL) will discontinue the following panels: Test code 6725 – HNPCC Comprehensive Panel – Sequence & Deletion/Duplication Analysis (MLH1, MSH2, MSH6) Test code 6726 – HNPCC PLUS Comprehensive Panel – Sequence & ...
Read More
Test Discontinuation Memorandum
Test Discontinuation Memorandum
Effective December 9, 2015, Baylor Miraca Genetics Laboratories (BMGL) will discontinue the following test: Test code 6084 – DMD Sequence Analysis For alternative testing, we offer DMD Comprehensive Analysis by Next Generation Sequencing (test code 20145) that includes sequencing and ...
Read More
Test Discontinuation Memorandum
Test Discontinuation Memorandum
Effective December 9, 2015, Baylor Miraca Genetics Laboratories (BMGL) will make the following modifications to its test menu: Test code 9126 (KRAS Mutation Analysis codons 12, 13, 61) will be replaced by test code 9128 (KRAS Mutation Analysis Codons 12, ...
Read More
Test Discontinuation Memorandum
Test Discontinuation Memorandum
Effective August 10, 2015, Baylor Miraca Genetics Labortories will discontinue the following test: Test code 9310 - UGT1A1 TA Repeat Analysis ...
Read More
Test Discontinuation Memorandum
Test Discontinuation Memorandum
Effective August 3, 2015, Baylor Miraca Genetics Laboratories (BMGL) will begin performing BRCA1 & BRCA2 sequencing analysis as an in-house test. As a result, BMGL will discontinue use of the following test code: Test code 1220 – BRCA1/2 Sequence & ...
Read More
Test Discontinuation Memorandum
Test Discontinuation Memorandum
Effective immediately, Baylor Miraca Genetics Laboratories will discontinue the following test: Test code 9610 – Cancer Exome Sequencing The following test codes may be considered as alternative ordering options: Test code 9705 – Cancer Gene Mutation Panel Version 2 (50 ...
Read More
Test Discontinuation Memorandum
Test Discontinuation Memorandum
Effective April 13, 2015, Baylor Miraca Genetics Laboratories will discontinue the following tests: Test Code: 6685 – TPMT Sequence Analysis Test Code: 6870 – Cytochrome P450 2C19 (CYP2C19) Genotyping Test code: 6875 – Cytochrome P450 2D6 (CYP2D6) Genotyping Test code: ...
Read More
Test Discontinuation Memorandum
Test Discontinuation Memorandum
Effective March 18, 2015, the Medical Genetics Laboratories at Baylor College of Medicine will discontinue the following tests: Test Code: 2335 – FBN1 Sequence Analysis Test Code: 2350 – RPGRIP1 Sequence Analysis Test Code: 2365 – GPR98 Sequence Analysis Test ...
Read More
Test Discontinuation Memorandum
Test Discontinuation Memorandum
Effective immediately, the Medical Genetics Laboratories at Baylor College of Medicine will discontinue test code 4572 – Hypoxanthine-Guanine Phosphoribosyltransferase (HPRT) Enzyme Analysis in red blood cells. A critical reagent for the assay is no longer available from the manufacturer; as ...
Read More
Test Discontinuation Memorandum
Test Discontinuation Memorandum
Effective November 17, 2014, the Medical Genetics Laboratories at Baylor College of Medicine will discontinue the following tests: 2103-CoQ10 Deficiency Deletion/Duplication Panel 2104-CoQ10 Comprehensive Panel (Massively Parallel Sequencing and Deletion/Duplication Analysis) 2123-Cobalamin Metabolism Deletion/Duplication Panel 2124-Cobalamin Metabolism Comprehensive Panel (Massively ...
Read More
Test Discontinuation Memorandum
Test Discontinuation Memorandum
Effective September 15, 2014, the Medical Genetics Laboratories at Baylor College of Medicine will discontinue the following tests: 9090 – MAX Sequence Analysis 9025 – AKT1 Mutation Analysis - Tumor (FFPE Tissue) 9026 – AKT1 Mutation Analysis - Tumor (Fresh ...
Read More
Test Discontinuation Memorandum
Test Discontinuation Memorandum
Effective September 12, 2014, the Medical Genetics Laboratories at Baylor College of Medicine will discontinue Test Codes: Test Code: 3788 - LDHA Deletion/Duplication Analysis Test Code: 3789 - LDHA Comprehensive Sequence and Deletion/Duplication Analysis ...
Read More
Test Discontinuation Memorandum
Test Discontinuation Memorandum
Effective September 3, 2014, the Medical Genetics Laboratories at Baylor College of Medicine will discontinue the following tests: 9130 – Comprehensive Hereditary Cancer Panel (47 genes) 9135 – Pheochromocytoma/Paraganglioma Panel (9 genes) 9145 – High Risk Colorectal Panel (11 genes) ...
Read More
Test Discontinuation Memorandum
Test Discontinuation Memorandum
Effective June 11th, 2014, the Medical Genetics Laboratories at Baylor College of Medicine will discontinue the following test: Test Code 2870 – Maple Syrup Urine Disease Panel As an alternative to this discontinued test, we recommend ordering Test Code 32870 ...
Read More
Test Discontinuation Memorandum
Test Discontinuation Memorandum
Effective April 21, 2014, the Medical Genetics Laboratories at Baylor College of Medicine will discontinue the following tests: Test Code 3105 - Complex IV (COX) Deficiency Panel - Nuclear Genes Test Code 3335 - mtDNA Depletion Panel, Hepatocerebral Form Test ...
Read More
Test Discontinuation Memorandum
Test Discontinuation Memorandum
This memo is to inform you that the Medical Genetics Laboratories will discontinue the JAK2 R683 Mutation Analysis test effective February 20, 2014. We will continue to offer an extensive menu of cancer genetic tests including JAK2 V617F (Test Code 9010) and ...
Read More
Test Discontinuation Memorandum
Test Discontinuation Memorandum
Effective September 16, 2013 the Medical Genetics Laboratories at Baylor College of Medicine will discontinue offering the following test: Test code 3055 - Mitochondrial Whole Genome Sequence Analysis As an alternative to this discontinued test, we recommend ordering: Test Code ...
Read More
Test Discontinuation Memorandum
Test Discontinuation Memorandum
Effective December 15, 2012, the Cancer Genetics Laboratory at Baylor College of Medicine will discontinue the following tests: Test Code 9500 - Cancer Chromosomal Microarray, 180K CGH Test Code 9520 - 250K SNP Array As an alternative to these discontinued ...
Read More
Test Discontinuation Memorandum
Test Discontinuation Memorandum
What has changed Effective September 15th, 2012, the Medical Genetics Laboratories at Baylor College of Medicine will no longer offer the following tests: 3050 - Mitochondrial Complex I Subunits Sequence Analysis 3040 - Mitochondrial Cytochrome b Subunit Sequence Analysis 3035 ...
Read More
2009-2011 Test Discontinuation Memoranda
2009-2011 Test Discontinuation Memoranda
July 1, 2011 4512 - Fucosidase Enzyme Analysis - White Blood Cells (WBC) 4513 - Fucosidase Enzyme Analysis - Skin Fibroblast Culture (SFC) 4520 - Alpha-Glucosidase Enzyme Analysis - Skin Fibroblast Culture (SFC) 4519 - Alpha-Glucosidase Enzyme Analysis - Muscle ...
Read More